Proteomics: 4.8m people could pay for this biotechnology – and that’s just in the UK!
Listen to ASX-listed Proteomics MD Dr Richard Lipscombe talk to Matt Birney on the Bulls N’ Bears Report about Proteomics new UK distributor of its remarkable blood test that can predict the onset a particular disease in diabetics before symptoms even appear.